The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kaye Jack since year 2005.
The trader's CIK number is 1376099.
At the time of this reporting, Kaye Jack is the Director of Keryx Biopharmaceuticals Inc .
(stock ticker symbol KERX).
See this page for all insider trading activities at Keryx Biopharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2010-12-06||KERX||Keryx Biopharmaceuticals Inc||Sale||20,000||5.00||100,000|
|2010-09-29||KERX||Keryx Biopharmaceuticals Inc||Sale||25,000||5.02||125,499|
|2009-05-22||KERX||Keryx Biopharmaceuticals Inc||Buy||35,000||.43||15,015|
|2007-06-19||KERX||Keryx Biopharmaceuticals Inc||Buy||1,400||10.50||14,698|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kaye Jack (Director of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.